Breaking News
Top News
-
Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at
-
Ocular Therapeutix Inc. (OCUL) Appears Highly Attractive Following SOL-1 Clinical Trial Data
-
Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why
-
Opes Wealth Sells Its Entire FIXD Stake — Is This $9.3 Million Bond ETF Exit A Signal?
-
H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)
-
Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial
-
What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in
-
Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide
-
Galaxy Digital Leads Investment In Blockchain Startup Fence
-
German, Spanish Inflation Reach Multiyear Highs
-
Oil Rises as US-Iran Standoff Threatens Prolonged Supply Shock
-
Bank Groups Eye Changes to Fed’s Relaxed Capital Plans
-
Trump Signals No Letup of Naval Blockade, Tech Results on Deck | The Opening Trade 4/29/2026
-
European Sugar Rift Deepens Over Plan to Curb Duty-Free Imports
-
Kalshi, Polymarket Face New Rival in Crypto’s Hottest Exchange
-
US Core Capital Goods Orders Jump by Most Since 2020
-
Citi Picks Veteran Mideast Banker Tannir for Top Regional Role
-
Trump’s $1.5 Trillion Defense Budget Faces GOP Pushback
-
AbbVie Raises FY Guidance on Immunology, Neuroscience Growth
-
Lululemon Founder Takes Aim at New CEO Pick, Escalates Proxy Fight
2026-02-05








